DJIA 16,662.20 -218.16 -1.29%
NASDAQ 4,392.18 -70.72 -1.58%
S&P 500 1,941.78 -28.29 -1.44%
market minute promo

Repligen Corp (NASDAQ: RGEN)

21.34 -1.07 (-4.77%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RGEN $21.34 -4.77%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $22.19
Previous Close $22.41
Daily Range $21.31 - $22.19
52-Week Range $9.41 - $24.68
Market Cap $683.7M
P/E Ratio 40.02
Dividend (Yield) $0.00 (0.0%)
Volume 167,775
Average Daily Volume 444,383
Current FY EPS $0.29





Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website:

News & Commentary

This Week in Biotech: Clinical Success, Plus Wheeling and Dealing

Two positive clinical results, a symbiotic asset deal, and a rumored takeover target are this week's top stories in Part 2 of "This Week in Biotech."

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Stocks Hitting 52-Week Highs

XBI, MNKD, MACK, RGEN: ETF Outflow Alert

SPDR S&P Biotech ETF Experiences Big Outflow

Surges In Biotech Short Interest (INCY, PCYC, RGEN)

Sector Update: Healthcare Shares Mixed Pre-Market; Repligen's Earnings Nearly Double Estimates

Sector Update: Healthcare

Repligen: A Strong Investment For The Right Kind Of Investor

Noteworthy ETF Outflows: XBI, SRPT, MNKD, RGEN

RGEN: Insiders Vs. Shorts

See More RGEN News...

RGEN's Top Competitors

RGEN $21.34 (-4.77%)
Current stock: RGEN
AMGN $127.99 (-1.55%)
Current stock: AMGN
GILD $92.02 (-1.89%)
Current stock: GILD
BIIB $335.70 (-2.56%)
Current stock: BIIB